Tin tức & Cập nhật

Mom’s pre-existing diabetes tied to baby’s cancer risk

24 Feb 2021

Pre-existing diabetes in mothers, but not that which developed during pregnancy, appears to contribute to a heightened risk of childhood cancer in the offspring, particularly acute lymphoblastic leukaemia, according to a systematic review and meta-analysis.

Mom’s pre-existing diabetes tied to baby’s cancer risk

24 Feb 2021

Coffee intake tied to reduced prostate cancer risk

23 Feb 2021 bởi

A recent systematic review and meta-analysis suggested that increasing coffee consumption was tied to a reduced risk of prostate cancer.

Coffee intake tied to reduced prostate cancer risk

23 Feb 2021

Proton beam radiotherapy matches radiofrequency ablation in recurrent/residual HCC

23 Feb 2021

Proton beam radiotherapy (PBT) is a tolerable and safe approach to recurrent/residual hepatocellular carcinoma (rHCC) that yields comparable local progression-free survival (LPFS) rates to radiofrequency ablation (RFA), reports a recent study.

Proton beam radiotherapy matches radiofrequency ablation in recurrent/residual HCC

23 Feb 2021

Long-term prediagnostic aspirin use yields survival benefit in CRC

22 Feb 2021

Among patients with nonmetastatic colorectal cancer (CRC), long-term use of aspirin prior to diagnosis appears to cut the risk of CRC-specific mortality, a study has found.

Long-term prediagnostic aspirin use yields survival benefit in CRC

22 Feb 2021

Second-line avelumab shows therapeutic potential in advanced HCC

21 Feb 2021

Use of the antiprogrammed death ligand 1 (PD-L1) antibody avelumab in the second-line treatment of patients with advanced hepatocellular carcinoma (HCC) yields moderate efficacy with tolerable safety profile, according to the results of a phase II trial.

Second-line avelumab shows therapeutic potential in advanced HCC

21 Feb 2021

Occupational heat exposure may promote breast cancer

21 Feb 2021

Women exposed to heat at their workplaces risk developing breast cancer, according to a study.

Occupational heat exposure may promote breast cancer

21 Feb 2021

Camrelizumab–apatinib combo beneficial in advanced hepatocellular carcinoma

19 Feb 2021

The combination of camrelizumab, an antiprogrammed death monoclonal antibody, plus apatinib, a VEGFR-2 tyrosine kinase inhibitor, shows promise in the first- and second-line treatment of patients with advanced hepatocellular carcinoma, conferring survival benefits with manageable safety profile, according to the results of the phase II RESCUE trial.

Camrelizumab–apatinib combo beneficial in advanced hepatocellular carcinoma

19 Feb 2021

Overweight, centrally obese people at high risk of cancer at several sites

17 Feb 2021

The combination of general and central obesity contributes to an increased risk of cancer at several sites, according to a study, noting that some of these associations are sex-specific.

Overweight, centrally obese people at high risk of cancer at several sites

17 Feb 2021

Infigratinib emerges as potential treatment for advanced cholangiocarcinoma

16 Feb 2021 bởi

Infigratinib may be a suitable second- or later-line treatment option for patients with advanced or metastatic cholangiocarcinoma (CCA) with FGFR2* fusions or rearrangements, according to interim results of a phase II, open-label, single-arm study presented at ASCO GI 2021.

Infigratinib emerges as potential treatment for advanced cholangiocarcinoma

16 Feb 2021

Cabozantinib demonstrates favourable risk–benefit profile in pretreated advanced HCC

16 Feb 2021

Use of the vascular endothelial growth factor (VEGF) inhibitor cabozantinib in the second- or third-line treatment of patients with advanced hepatocellular carcinoma (HCC) appears to confer survival benefits without raising new safety concerns, according to the results of a phase II trial.

Cabozantinib demonstrates favourable risk–benefit profile in pretreated advanced HCC

16 Feb 2021

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Mom’s pre-existing diabetes tied to baby’s cancer risk

Mom’s pre-existing diabetes tied to baby’s cancer risk

Coffee intake tied to reduced prostate cancer risk

Coffee intake tied to reduced prostate cancer risk

Proton beam radiotherapy matches radiofrequency ablation in recurrent/residual HCC

Proton beam radiotherapy matches radiofrequency ablation in recurrent/residual HCC

Long-term prediagnostic aspirin use yields survival benefit in CRC

Long-term prediagnostic aspirin use yields survival benefit in CRC

Second-line avelumab shows therapeutic potential in advanced HCC

Second-line avelumab shows therapeutic potential in advanced HCC

Occupational heat exposure may promote breast cancer

Occupational heat exposure may promote breast cancer

Camrelizumab–apatinib combo beneficial in advanced hepatocellular carcinoma

Camrelizumab–apatinib combo beneficial in advanced hepatocellular carcinoma

Overweight, centrally obese people at high risk of cancer at several sites

Overweight, centrally obese people at high risk of cancer at several sites

Infigratinib emerges as potential treatment for advanced cholangiocarcinoma

Infigratinib emerges as potential treatment for advanced cholangiocarcinoma

Cabozantinib demonstrates favourable risk–benefit profile in pretreated advanced HCC

Cabozantinib demonstrates favourable risk–benefit profile in pretreated advanced HCC